Microbubble-enhanced transcranial focused ultrasound with temozolomide for patients with high-grade glioma (BT008NA): a multicentre, open-label, phase 1/2 trial.

Woodworth GF, Anastasiadis P, Ozair A, Chabros J, Bettegowda C, Chen C, Gerstl JVE, Douville C, Mekary RA, Smith TR, Meng Y, Hawkins C, Pople CB, Abrahao A, Llinas M, Heyn C, Bunevicius A, Rezai AR, Ball AJS, Henry K, Sahgal A, Torio E, Ren H, Ahmad H, Arora H, Eisenberg H, Perry J, Carpenter JS, Hynynen K, Pham LC, Anketell MB, Lim-Fat MJ, Xu Z, Cifarelli CP, Sheehan JP, McDannold NJ, Gandhi D, Golby AJ, Lipsman N

Open source

DOI: 10.1016/s1470-2045(25)00492-9
Published: 2025 Dec
Container: The Lancet. Oncology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/s1470-2045-25-00492-9,
  title = {Microbubble-enhanced transcranial focused ultrasound with temozolomide for patients with high-grade glioma (BT008NA): a multicentre, open-label, phase 1/2 trial.},
  author = {Woodworth GF and Anastasiadis P and Ozair A and Chabros J and Bettegowda C and Chen C and Gerstl JVE and Douville C and Mekary RA and Smith TR and Meng Y and Hawkins C and Pople CB and Abrahao A and Llinas M and Heyn C and Bunevicius A and Rezai AR and Ball AJS and Henry K and Sahgal A and Torio E and Ren H and Ahmad H and Arora H and Eisenberg H and Perry J and Carpenter JS and Hynynen K and Pham LC and Anketell MB and Lim-Fat MJ and Xu Z and Cifarelli CP and Sheehan JP and McDannold NJ and Gandhi D and Golby AJ and Lipsman N},
  year = {2025},
  journal = {The Lancet. Oncology},
  doi = {10.1016/s1470-2045(25)00492-9},
  url = {https://doi.org/10.1016/s1470-2045(25)00492-9}
}

RIS

TY  - JOUR
TI  - Microbubble-enhanced transcranial focused ultrasound with temozolomide for patients with high-grade glioma (BT008NA): a multicentre, open-label, phase 1/2 trial.
AU  - Woodworth GF
AU  - Anastasiadis P
AU  - Ozair A
AU  - Chabros J
AU  - Bettegowda C
AU  - Chen C
AU  - Gerstl JVE
AU  - Douville C
AU  - Mekary RA
AU  - Smith TR
AU  - Meng Y
AU  - Hawkins C
AU  - Pople CB
AU  - Abrahao A
AU  - Llinas M
AU  - Heyn C
AU  - Bunevicius A
AU  - Rezai AR
AU  - Ball AJS
AU  - Henry K
AU  - Sahgal A
AU  - Torio E
AU  - Ren H
AU  - Ahmad H
AU  - Arora H
AU  - Eisenberg H
AU  - Perry J
AU  - Carpenter JS
AU  - Hynynen K
AU  - Pham LC
AU  - Anketell MB
AU  - Lim-Fat MJ
AU  - Xu Z
AU  - Cifarelli CP
AU  - Sheehan JP
AU  - McDannold NJ
AU  - Gandhi D
AU  - Golby AJ
AU  - Lipsman N
PY  - 2025
JO  - The Lancet. Oncology
DO  - 10.1016/s1470-2045(25)00492-9
UR  - https://doi.org/10.1016/s1470-2045(25)00492-9
ER  -

APA

GF, W., P, A., A, O., J, C., C, B., C, C., JVE, G., C, D., RA, M., TR, S., Y, M., C, H., CB, P., A, A., M, L., C, H., A, B., AR, R., AJS, B., K, H., A, S., E, T., H, R., H, A., H, A., H, E., J, P., JS, C., K, H., LC, P., MB, A., MJ, L., Z, X., CP, C., JP, S., NJ, M., D, G., AJ, G., & N, L. (2025). Microbubble-enhanced transcranial focused ultrasound with temozolomide for patients with high-grade glioma (BT008NA): a multicentre, open-label, phase 1/2 trial.. The Lancet. Oncology. https://doi.org/10.1016/s1470-2045(25)00492-9

Source records

pubmed · retrieved 2026-11-10T14:42:52.285Z